Sartan APIs

Founded in 1999, Zhuhai Rundu Pharmaceutical Co., Ltd. is located in Jinwan District, Zhuhai City, Guangdong Province. It is a modern high-tech pharmaceutical enterprise integrating drug R & D, production and sales. Its main business includes pharmaceutical intermediates, APIs, preparations and other diversified sectors. Rundu Co., Ltd. has three subsidiaries, namely Zhuhai mintong Pharmaceutical Co., Ltd., Rundu Pharmaceutical (Wuhan) Research Institute Co., Ltd. and Rundu Pharmaceutical (Jingmen) Co., Ltd.

On January 5, 2018, the company was listed on Shenzhen Stock Exchange; Stock Code: 002923). The company has a registered capital of 185 million yuan, total assets of 1.519 billion yuan and more than 1000 employees. The company has been recognized as a national high-tech enterprise, a national enterprise technology center, a National Postdoctoral research station, and a major contributor to the pharmaceutical industry in Guangdong Province.

In the future, the company will take becoming an international pharmaceutical company with characteristics as its development goal, adhering to the business philosophy of "standardization, specialty and development", focusing on achieving excellence, carrying forward the future with technology, realizing the healthy development of the enterprise, and constantly striving to improve human health!